Industry Research Reports
Home > Reports > Service & Software > Global Data-Driven Quality Assurance in Pharma Manufacturing Market Insights, Forecast to 2031
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Insights, Forecast to 2031
Industry: Service & Software
Published Date: 2025-05-16
Pages: 137 Pages
Report ld: 4738549
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Data-Driven Quality Assurance in Pharma Manufacturing Market Size(US$)
CAGR 2025-2031
13.2%
Market Size,2031
USD 5,006
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,379 million
Market Forecast in 2031(Value)
US$ 5,006 million
CAGR
13.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5006 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.2% during the forecast period.
This report mainly focuses on data-driven quality assurance in pharma manufacturing market. Data-driven quality assurance (DD-QA) refers to the process of pharmaceutical production, through real-time collection, analysis and use of production data (such as process parameters, equipment status, environmental monitoring, quality inspection, etc.), to monitor, predict and optimize production quality in a scientific and automated manner to ensure that drugs comply with regulatory requirements (such as GMP) and improve production efficiency. The core is to use data as the basis for quality decision-making, reduce human intervention, and improve the accuracy and traceability of quality control.
The US & Canada market for Data-Driven Quality Assurance in Pharma Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Data-Driven Quality Assurance in Pharma Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Data-Driven Quality Assurance in Pharma Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key manufacturers of Data-Driven Quality Assurance in Pharma Manufacturing include FirstEigen, EVERSANA, Ideagen, Incepbio, Exor International S.p.A., ComplianceQuest, Vimachem, Proscia, Amplelogic, Freyr Solutions, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Data-Driven Quality Assurance in Pharma Manufacturing production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Data-Driven Quality Assurance in Pharma Manufacturing by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Data-Driven Quality Assurance in Pharma Manufacturing, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Data-Driven Quality Assurance in Pharma Manufacturing, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Data-Driven Quality Assurance in Pharma Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Data-Driven Quality Assurance in Pharma Manufacturing sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Data-Driven Quality Assurance in Pharma Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Data-Driven Quality Assurance in Pharma Manufacturing sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including FirstEigen, EVERSANA, Ideagen, Incepbio, Exor International S.p.A., ComplianceQuest, Vimachem, Proscia, Amplelogic, Freyr Solutions, etc.
MARKET SEGMENTATION
By Company
- FirstEigen
- EVERSANA
- Ideagen
- Incepbio
- Exor International S.p.A.
- ComplianceQuest
- Vimachem
- Proscia
- Amplelogic
- Freyr Solutions
- Thermo Fisher SampleManager LIMS
- Dassault Systèmes
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Real-time Monitoring
- Statistical Quality Control
- Others
Segment by Application
- Process Development and Optimization
- Production Process Control
- Quality Inspection and Release
- Supply Chain and Materials Management
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Data-Driven Quality Assurance in Pharma Manufacturing production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Data-Driven Quality Assurance in Pharma Manufacturing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Data-Driven Quality Assurance in Pharma Manufacturing manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Data-Driven Quality Assurance in Pharma Manufacturing sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Real-time Monitoring
1.2.3 Statistical Quality Control
1.2.4 Others
1.3 Market by Application
1.3.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Process Development and Optimization
1.3.3 Production Process Control
1.3.4 Quality Inspection and Release
1.3.5 Supply Chain and Materials Management
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Perspective (2020-2031)
2.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Growth Trends by Region
2.2.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Region (2020-2031)
2.3 Data-Driven Quality Assurance in Pharma Manufacturing Market Dynamics
2.3.1 Data-Driven Quality Assurance in Pharma Manufacturing Industry Trends
2.3.2 Data-Driven Quality Assurance in Pharma Manufacturing Market Drivers
2.3.3 Data-Driven Quality Assurance in Pharma Manufacturing Market Challenges
2.3.4 Data-Driven Quality Assurance in Pharma Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Data-Driven Quality Assurance in Pharma Manufacturing by Players
3.1.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Players (2020-2025)
3.1.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Data-Driven Quality Assurance in Pharma Manufacturing Revenue in 2024
3.5 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing Head office and Area Served
3.6 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Product and Application
3.7 Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
5.1 Global Data-Driven Quality Assurance in Pharma Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Data-Driven Quality Assurance in Pharma Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2031)
6.2.2 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2031)
6.3.2 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2031)
7.2.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2031)
7.3.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Data-Driven Quality Assurance in Pharma Manufacturing Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2031)
8.2.2 China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2031)
8.3.2 China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2031)
9.2.2 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2031)
9.3.2 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries
11 Key Players Profiles
11.1 FirstEigen
11.1.1 FirstEigen Company Details
11.1.2 FirstEigen Business Overview
11.1.3 FirstEigen Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.1.4 FirstEigen Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.1.5 FirstEigen Recent Development
11.2 EVERSANA
11.2.1 EVERSANA Company Details
11.2.2 EVERSANA Business Overview
11.2.3 EVERSANA Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.2.4 EVERSANA Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.2.5 EVERSANA Recent Development
11.3 Ideagen
11.3.1 Ideagen Company Details
11.3.2 Ideagen Business Overview
11.3.3 Ideagen Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.3.4 Ideagen Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.3.5 Ideagen Recent Development
11.4 Incepbio
11.4.1 Incepbio Company Details
11.4.2 Incepbio Business Overview
11.4.3 Incepbio Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.4.4 Incepbio Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.4.5 Incepbio Recent Development
11.5 Exor International S.p.A.
11.5.1 Exor International S.p.A. Company Details
11.5.2 Exor International S.p.A. Business Overview
11.5.3 Exor International S.p.A. Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.5.4 Exor International S.p.A. Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.5.5 Exor International S.p.A. Recent Development
11.6 ComplianceQuest
11.6.1 ComplianceQuest Company Details
11.6.2 ComplianceQuest Business Overview
11.6.3 ComplianceQuest Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.6.4 ComplianceQuest Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.6.5 ComplianceQuest Recent Development
11.7 Vimachem
11.7.1 Vimachem Company Details
11.7.2 Vimachem Business Overview
11.7.3 Vimachem Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.7.4 Vimachem Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.7.5 Vimachem Recent Development
11.8 Proscia
11.8.1 Proscia Company Details
11.8.2 Proscia Business Overview
11.8.3 Proscia Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.8.4 Proscia Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.8.5 Proscia Recent Development
11.9 Amplelogic
11.9.1 Amplelogic Company Details
11.9.2 Amplelogic Business Overview
11.9.3 Amplelogic Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.9.4 Amplelogic Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.9.5 Amplelogic Recent Development
11.10 Freyr Solutions
11.10.1 Freyr Solutions Company Details
11.10.2 Freyr Solutions Business Overview
11.10.3 Freyr Solutions Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.10.4 Freyr Solutions Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.10.5 Freyr Solutions Recent Development
11.11 Thermo Fisher SampleManager LIMS
11.11.1 Thermo Fisher SampleManager LIMS Company Details
11.11.2 Thermo Fisher SampleManager LIMS Business Overview
11.11.3 Thermo Fisher SampleManager LIMS Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.11.4 Thermo Fisher SampleManager LIMS Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.11.5 Thermo Fisher SampleManager LIMS Recent Development
11.12 Dassault Systèmes
11.12.1 Dassault Systèmes Company Details
11.12.2 Dassault Systèmes Business Overview
11.12.3 Dassault Systèmes Data-Driven Quality Assurance in Pharma Manufacturing Introduction
11.12.4 Dassault Systèmes Revenue in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
11.12.5 Dassault Systèmes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Real-time Monitoring
Table 3. Key Players of Statistical Quality Control
Table 4. Key Players of Others
Table 5. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Market Size by Region (2020-2031) & (US$ Million)
Table 8. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Region (2020-2031)
Table 9. Market Trends
Table 10. Market Drivers
Table 11. Market Challenges
Table 12. Market Restraints
Table 13. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 14. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Players (2020-2025)
Table 15. Global Top Data-Driven Quality Assurance in Pharma Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Data-Driven Quality Assurance in Pharma Manufacturing as of 2024)
Table 16. Global Data-Driven Quality Assurance in Pharma Manufacturing Industry Ranking 2023 VS 2024
Table 17. Global 5 Largest Players Market Share by Data-Driven Quality Assurance in Pharma Manufacturing Revenue (CR5 and HHI) & (2020-2025)
Table 18. Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Headquarters and Area Served
Table 19. Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Product and Application
Table 20. Global Key Players of Data-Driven Quality Assurance in Pharma Manufacturing, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Market Size by Type (2020-2025) & (US$ Million)
Table 23. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Market Share by Type (2020-2025)
Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 25. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Market Share by Type (2026-2031)
Table 26. Global Market Size by Application (2020-2025) & (US$ Million)
Table 27. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Market Share by Application (2020-2025)
Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 29. Global Data-Driven Quality Assurance in Pharma Manufacturing Revenue Market Share by Application (2026-2031)
Table 30. North America Market Size by Type (2020-2031) & (US$ Million)
Table 31. North America Market Size by Application (2020-2031) & (US$ Million)
Table 32. North America Data-Driven Quality Assurance in Pharma Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Market Size by Country (2020-2031) & (US$ Million)
Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)
Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)
Table 36. Europe Data-Driven Quality Assurance in Pharma Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)
Table 38. China Market Size by Type (2020-2031) & (US$ Million)
Table 39. China Market Size by Application (2020-2031) & (US$ Million)
Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)
Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)
Table 42. Asia Data-Driven Quality Assurance in Pharma Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)
Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
Table 46. Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
Table 48. FirstEigen Company Details
Table 49. FirstEigen Business Overview
Table 50. FirstEigen Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 51. FirstEigen Revenue (2020-2025) & (US$ Million)
Table 52. FirstEigen Recent Development
Table 53. EVERSANA Company Details
Table 54. EVERSANA Business Overview
Table 55. EVERSANA Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 56. EVERSANA Revenue (2020-2025) & (US$ Million)
Table 57. EVERSANA Recent Development
Table 58. Ideagen Company Details
Table 59. Ideagen Business Overview
Table 60. Ideagen Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 61. Ideagen Revenue (2020-2025) & (US$ Million)
Table 62. Ideagen Recent Development
Table 63. Incepbio Company Details
Table 64. Incepbio Business Overview
Table 65. Incepbio Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 66. Incepbio Revenue (2020-2025) & (US$ Million)
Table 67. Incepbio Recent Development
Table 68. Exor International S.p.A. Company Details
Table 69. Exor International S.p.A. Business Overview
Table 70. Exor International S.p.A. Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 71. Exor International S.p.A. Revenue (2020-2025) & (US$ Million)
Table 72. Exor International S.p.A. Recent Development
Table 73. ComplianceQuest Company Details
Table 74. ComplianceQuest Business Overview
Table 75. ComplianceQuest Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 76. ComplianceQuest Revenue (2020-2025) & (US$ Million)
Table 77. ComplianceQuest Recent Development
Table 78. Vimachem Company Details
Table 79. Vimachem Business Overview
Table 80. Vimachem Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 81. Vimachem Revenue (2020-2025) & (US$ Million)
Table 82. Vimachem Recent Development
Table 83. Proscia Company Details
Table 84. Proscia Business Overview
Table 85. Proscia Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 86. Proscia Revenue (2020-2025) & (US$ Million)
Table 87. Proscia Recent Development
Table 88. Amplelogic Company Details
Table 89. Amplelogic Business Overview
Table 90. Amplelogic Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 91. Amplelogic Revenue (2020-2025) & (US$ Million)
Table 92. Amplelogic Recent Development
Table 93. Freyr Solutions Company Details
Table 94. Freyr Solutions Business Overview
Table 95. Freyr Solutions Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 96. Freyr Solutions Revenue (2020-2025) & (US$ Million)
Table 97. Freyr Solutions Recent Development
Table 98. Thermo Fisher SampleManager LIMS Company Details
Table 99. Thermo Fisher SampleManager LIMS Business Overview
Table 100. Thermo Fisher SampleManager LIMS Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 101. Thermo Fisher SampleManager LIMS Revenue (2020-2025) & (US$ Million)
Table 102. Thermo Fisher SampleManager LIMS Recent Development
Table 103. Dassault Systèmes Company Details
Table 104. Dassault Systèmes Business Overview
Table 105. Dassault Systèmes Data-Driven Quality Assurance in Pharma Manufacturing Product
Table 106. Dassault Systèmes Revenue (2020-2025) & (US$ Million)
Table 107. Dassault Systèmes Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 2. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type: 2024 VS 2031
Figure 3. Real-time Monitoring Features
Figure 4. Statistical Quality Control Features
Figure 5. Others Features
Figure 6. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application: 2024 VS 2031
Figure 8. Process Development and Optimization Case Studies
Figure 9. Production Process Control Case Studies
Figure 10. Quality Inspection and Release Case Studies
Figure 11. Supply Chain and Materials Management Case Studies
Figure 12. Others Case Studies
Figure 13. Data-Driven Quality Assurance in Pharma Manufacturing Report Years Considered
Figure 14. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Region: 2024 VS 2031
Figure 17. Global Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Players in 2024
Figure 18. Global Top Data-Driven Quality Assurance in Pharma Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Data-Driven Quality Assurance in Pharma Manufacturing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Data-Driven Quality Assurance in Pharma Manufacturing Revenue in 2024
Figure 20. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
Figure 22. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
Figure 23. North America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Country (2020-2031)
Figure 24. United States Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
Figure 28. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
Figure 29. Europe Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Country (2020-2031)
Figure 30. Germany Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. China Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
Figure 38. China Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
Figure 39. Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
Figure 41. Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
Figure 42. Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Region (2020-2031)
Figure 43. Japan Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. South Korea Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. China Taiwan Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Type (2020-2031)
Figure 51. Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Application (2020-2031)
Figure 52. Middle East, Africa, and Latin America Data-Driven Quality Assurance in Pharma Manufacturing Market Share by Country (2020-2031)
Figure 53. Brazil Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Mexico Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Turkey Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Israel Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. GCC Countries Data-Driven Quality Assurance in Pharma Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. FirstEigen Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 60. EVERSANA Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 61. Ideagen Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 62. Incepbio Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 63. Exor International S.p.A. Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 64. ComplianceQuest Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 65. Vimachem Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 66. Proscia Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 67. Amplelogic Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 68. Freyr Solutions Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 69. Thermo Fisher SampleManager LIMS Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 70. Dassault Systèmes Revenue Growth Rate in Data-Driven Quality Assurance in Pharma Manufacturing Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Data-Driven Quality Assurance in Pharma Manufacturing market?
The top companies in the global Data-Driven Quality Assurance in Pharma Manufacturing market are FirstEigen、EVERSANA、Ideagen.
What was the global market size of Data-Driven Quality Assurance in Pharma Manufacturing in 2025?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Data-Driven Quality Assurance in Pharma Manufacturing market size from 2025 to 2031?
What was the global market size of Data-Driven Quality Assurance in Pharma Manufacturing in 2031?
Related Reports
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5600 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 137
USD 4900.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2379 million in 2025 and is forecast to reach a readjusted size of US$ 5600 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 91
USD 4250.00
(Single User License)
Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2379 million in 2025 and is projected to reach US$ 5600 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 115
USD 3950.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2026
The global Data-Driven Quality Assurance in Pharma Manufacturing market was valued at US$ 2379 million in 2025 and is anticipated to reach US$ 5600 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 118
USD 2900.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published Date: 2025-05-16
Pages: 99
USD 4250.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2025
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was valued at US$ 2130 million in the year 2024 and is projected to reach a revised size of US$ 5006 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Published Date: 2025-05-16
Pages: 85
USD 2900.00
(Single User License)
Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published Date: 2025-05-16
Pages: 105
USD 3950.00
(Single User License)
Global Data-Driven Quality Assurance in Pharma Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Data-Driven Quality Assurance in Pharma Manufacturing market is projected to grow from US$ 2379 million in 2025 to US$ 5600 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 137
USD 4900.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2379 million in 2025 and is forecast to reach a readjusted size of US$ 5600 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 91
USD 4250.00 (Single User License)Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2379 million in 2025 and is projected to reach US$ 5600 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 115
USD 3950.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2026
The global Data-Driven Quality Assurance in Pharma Manufacturing market was valued at US$ 2379 million in 2025 and is anticipated to reach US$ 5600 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 118
USD 2900.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Data-Driven Quality Assurance in Pharma Manufacturing market size was US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published: 2025-05-16
Pages: 99
USD 4250.00 (Single User License)Global Data-Driven Quality Assurance in Pharma Manufacturing Market Research Report 2025
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was valued at US$ 2130 million in the year 2024 and is projected to reach a revised size of US$ 5006 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Published: 2025-05-16
Pages: 85
USD 2900.00 (Single User License)Data-Driven Quality Assurance in Pharma Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Data-Driven Quality Assurance in Pharma Manufacturing was estimated to be worth US$ 2130 million in 2024 and is forecast to a readjusted size of US$ 5006 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.
Published: 2025-05-16
Pages: 105
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now